News about Manufacturing

Eli Lilly to Pour USD 1.2B into Puerto Rico Facility Expansion Amid USA Manufacturing Push

Eli Lilly to Pour USD 1.2B into Puerto Rico Facility Expansion Amid USA Manufacturing Push

Eli Lilly announced plans to invest more than USD 1.2 billion to expand and modernise its Lilly del Caribe manufacturing site in Carolina, Puerto Rico, as part of its broader initiative to enhance pharmaceutical production in the United States.

Manufacturing | 03/11/2025 | By Darshana

Codexis and Nitto Denko Avecia Partner to Advance Enzymatic Oligonucleotide Manufacturing

Codexis and Nitto Denko Avecia Partner to Advance Enzymatic Oligonucleotide Manufacturing

Under the agreement, Nitto Denko Avecia will evaluate Codexis’ ECO Synthesis™ Manufacturing Platform, an enzyme-catalysed alternative to traditional solid-phase oligonucleotide synthesis.

Manufacturing | 01/11/2025 | By Darshana

Ajinomoto Bio-Pharma and Olon Forge Partnership to Advance Sustainable Biologics Manufacturing

Ajinomoto Bio-Pharma and Olon Forge Partnership to Advance Sustainable Biologics Manufacturing

Ajinomoto Bio-Pharma Services (Aji Bio-Pharma), a global leader in biopharmaceutical contract development and manufacturing, has entered into a strategic partnership with Olon S.p.A. to provide innovative, large-scale drug substance manufacturing solutions for pharmaceutical and biotechnology clients.

Manufacturing | 30/10/2025 | By Darshana

Sai Life Sciences Set to Double Process R&D Capacity with New Facility in Hyderabad

Sai Life Sciences Set to Double Process R&D Capacity with New Facility in Hyderabad

The upcoming Process R&D Block at Sai Life Sciences will cover 100,000 sq. ft. across five floors, featuring 140 process chemistry fume hoods, an integrated satellite analytical lab, and dedicated peptide and oligo labs, supported by a 25,000 sq. ft. central analytical facility.

Manufacturing | 28/10/2025 | By Dineshwori

Merck Commits More Than USD 70 Billion to USA Manufacturing and R&D Expansion

Merck Commits More Than USD 70 Billion to USA Manufacturing and R&D Expansion

A central component of this investment is the construction of a USD 3 billion pharmaceutical manufacturing facility in Elkton, Virginia, which is expected to generate around 500 permanent jobs and several thousand construction roles.

Manufacturing | 21/10/2025 | By Darshana

ACG Announces USD 200 Million Investment for Empty-Capsule Manufacturing In the US

ACG Announces USD 200 Million Investment for Empty-Capsule Manufacturing In the US

ACG has announced a USD 200 million phased investment to establish its first empty-capsule manufacturing operations in the United States.

Manufacturing | 21/10/2025 | By Dineshwori 126

Ipca Laboratories Expands Global Footprint with New German Subsidiary

Ipca Laboratories Expands Global Footprint with New German Subsidiary

Ipca Laboratories has announced the incorporation of its wholly owned subsidiary, Ipca Pharmaceuticals GmbH, in the Federal Republic of Germany with an initial paid-up capital of Euro 25,000.

Manufacturing | 16/10/2025 | By Dineshwori 108

Nasus Pharma Partners with Aptar to Strengthen Commercialisation of Intranasal Epinephrine

Nasus Pharma Partners with Aptar to Strengthen Commercialisation of Intranasal Epinephrine

The collaboration aims to advance the clinical development and future commercialisation of NS002, Nasus Pharma’s intranasal powder epinephrine product candidate.

Manufacturing | 13/10/2025 | By Darshana

Sonoma Pharmaceuticals Expands Manufacturing Scope with US FDA MoCRA Registration for Microcyn-Based Facial Spray

Sonoma Pharmaceuticals Expands Manufacturing Scope with US FDA MoCRA Registration for Microcyn-Based Facial Spray

The facility was already US FDA-registered as a medical device establishment, supporting a portfolio of 510(k)-cleared products across multiple therapeutic categories.

Manufacturing | 11/10/2025 | By Darshana

GKB Ophthalmics Cuts Production at Goa Plant Amid Sluggish Market Demand

GKB Ophthalmics Cuts Production at Goa Plant Amid Sluggish Market Demand

GKB Ophthalmics has reduced production to 50 percent at its Tivim Industrial Estate plant in Mapusa, Goa, due to a slowdown in market demand and the complete suspension of export orders from its US subsidiary starting October 2025, following the imposition of heavy tariffs.

Manufacturing | 11/10/2025 | By Dineshwori

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members